APDN vs. LGMK, SPCB, JCSE, MOB, ADN, CRKN, GWAV, SMIT, BBIG, and HUBC
Should you be buying Applied DNA Sciences stock or one of its competitors? The main competitors of Applied DNA Sciences include LogicMark (LGMK), SuperCom (SPCB), JE Cleantech (JCSE), Mobilicom (MOB), Advent Technologies (ADN), Crown ElectroKinetics (CRKN), Greenwave Technology Solutions (GWAV), Schmitt Industries (SMIT), Vinco Ventures (BBIG), and HUB Cyber Security (HUBC). These companies are all part of the "industrial products" sector.
Applied DNA Sciences (NASDAQ:APDN) and LogicMark (NASDAQ:LGMK) are both small-cap industrial products companies, but which is the better investment? We will compare the two businesses based on the strength of their profitability, analyst recommendations, community ranking, valuation, media sentiment, institutional ownership, risk, earnings and dividends.
22.2% of Applied DNA Sciences shares are owned by institutional investors. Comparatively, 7.9% of LogicMark shares are owned by institutional investors. 10.3% of Applied DNA Sciences shares are owned by insiders. Comparatively, 12.4% of LogicMark shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.
Applied DNA Sciences has a beta of 0.26, meaning that its share price is 74% less volatile than the S&P 500. Comparatively, LogicMark has a beta of 1.38, meaning that its share price is 38% more volatile than the S&P 500.
Applied DNA Sciences received 292 more outperform votes than LogicMark when rated by MarketBeat users.
In the previous week, Applied DNA Sciences and Applied DNA Sciences both had 3 articles in the media. LogicMark's average media sentiment score of 1.48 beat Applied DNA Sciences' score of 0.94 indicating that LogicMark is being referred to more favorably in the news media.
LogicMark has a net margin of -148.63% compared to Applied DNA Sciences' net margin of -222.33%. LogicMark's return on equity of -86.78% beat Applied DNA Sciences' return on equity.
Applied DNA Sciences has higher earnings, but lower revenue than LogicMark. LogicMark is trading at a lower price-to-earnings ratio than Applied DNA Sciences, indicating that it is currently the more affordable of the two stocks.
Applied DNA Sciences presently has a consensus target price of $7.00, indicating a potential upside of 939.04%. Given Applied DNA Sciences' higher probable upside, research analysts plainly believe Applied DNA Sciences is more favorable than LogicMark.
Summary
LogicMark beats Applied DNA Sciences on 9 of the 15 factors compared between the two stocks.
Get Applied DNA Sciences News Delivered to You Automatically
Sign up to receive the latest news and ratings for APDN and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding APDN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Applied DNA Sciences Competitors List
Related Companies and Tools
